TRELLUS HEALTH LS -0006

Research TRELLUS HEALTH LS -0006 (85Q) on Bullrun: market cap EUR 215.06K. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Valuation Snapshot

latest market cap is EUR 215.06K.

Five-year financial history

YearRevenueNet incomeFree cash flowGross marginDiluted EPSCashTotal debtEquity
FY2024USD 114.00K-USD 7.78M-USD 7.86M100.0%-0.05USD 4.34Mn/aUSD 11.77M
FY2023USD 19.00K-USD 6.34M-USD 7.63M100.0%-0.04USD 12.17Mn/aUSD 19.50M
FY2022USD 18.00K-USD 8.81M-USD 11.53M100.0%-0.05USD 19.09Mn/aUSD 25.09M
FY2021USD 25.00K-USD 5.90M-USD 8.49M100.0%-0.04USD 31.98Mn/aUSD 35.27M

Valuation history

YearSnapshot dateMarket capP/EDividend yieldAnnual dividend/share
20262026-08-17EUR 215.06Kn/an/a0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 EUR.

About TRELLUS HEALTH LS -0006

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.

Related stock research

Other Healthcare stocks

Frequently asked questions

What is TRELLUS HEALTH LS -0006's market cap?

TRELLUS HEALTH LS -0006's market capitalization is EUR 215.06K.

What does TRELLUS HEALTH LS -0006 do?

Trellus Health plc provides digital chronic condition management solutions for employers and health plans. The company offers GRITT resilience-based methodology; and TrellusElevate, a HIPAA-compliant technology platform for remote telemedicine care. Its platform provides support for managing inflammatory bowel disease, including Crohn's Disease and ulcerative colitis. The company was incorporated in 2020 and is headquartered in White Plains, New York.